Trial Profile
A Randomized, Double-Blind, Multicenter Study to Compare the Immunological Efficacy and Safety of GC3110B With GCFLU Quadrivalent Inj. Administered Intramuscularly in Healthy Adults
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 10 Sep 2018
Price :
$35
*
At a glance
- Drugs GC 3110A (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics; Registrational
- Sponsors GC Biopharma
- 03 Oct 2016 New trial record